102 Grants (Page 2 of 5)
2013
Role of Microenvironmental-Derived AXII in Myeloma Bone Disease
Roodman, Garson D
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 7I01CX000623-02), 07/01/2012 -- 06/30/2016
 
Role of Microenvironmental-Derived AXII in Myeloma Bone Disease
Roodman, Garson D
National Institutes of Health (NIH), Veterans Affairs (VA) (ID: 1I01CX000623-01), 07/01/2012 -- 06/30/2016
2012
GFI-1 and Osteoblast Suppression in Multiple Myeloma
Galson, Deborah L and Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5R01AR059679-03), $277,603USD, 07/26/2010 -- 06/30/2015
 
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR057308-06), $349,723USD, 09/15/2008 -- 05/08/2014
2011
AXII in the Multiple Myeloma Bone Microenvironment
Roodman, Garson D
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 7R21CA141426-03), $71,628USD, 03/01/2010 -- 02/28/2013
 
AXII in the Multiple Myeloma Bone Microenvironment
Roodman, Garson D
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 5R21CA141426-02), $101,332USD, 03/01/2010 -- 11/15/2011
 
GFI-1 and Osteoblast Suppression in Multiple Myeloma
Galson, Deborah L and Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5R01AR059679-02), $277,603USD, 07/26/2010 -- 06/30/2015
 
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR057308-04), $144,762USD, 09/15/2008 -- 11/15/2011
 
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 7R01AR057308-05), $171,520USD, 09/15/2008 -- 08/31/2013
2010
AXII in the Multiple Myeloma Bone Microenvironment
Roodman, Garson D
National Institutes of Health (NIH), National Cancer Institute (NCI) (ID: 1R21CA141426-01A1), $151,017USD, 03/01/2010 -- 02/29/2012
 
GFI-1 and Osteoblast Suppression in Multiple Myeloma
Galson, Deborah L and Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 1R01AR059679-01), $294,863USD, 07/26/2010 -- 06/30/2015
 
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR057308-03), $336,592USD, 09/15/2008 -- 08/31/2013
2009
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 3R01AR057308-02S1), $610,272USD, 09/28/2009 -- 09/27/2011
 
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR057308-02), $331,179USD, 09/15/2008 -- 08/31/2013
 
Osteoclasts from Transgenic Mice
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR041336-18), $256,441USD, 09/30/1991 -- 06/30/2011
2008
MVNP, p62P392L and IL-6 in the Pathogenesis of PD
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 1R01AR057308-01), $345,005USD, 09/15/2008 -- 08/31/2013
 
Osteoclasts from Transgenic Mice
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5R01AR041336-17), $256,458USD, 09/30/1991 -- 06/30/2010
2007
Administrative Core
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5P01AR049363-05), $80,747USD, 09/01/2007 -- 08/31/2008
 
Development of In Vivo Models of Paget's Disease
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 5P01AR049363-05-0002), $200,071USD, 09/01/2007 -- 08/31/2008
 
Osteoclasts from Transgenic Mice
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR041336-16), $261,708USD, 09/30/1991 -- 06/30/2010
 
Program Project Grant-Pathobiology of Paget's Disease
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5P01AR049363-05), $778,991USD, 09/29/2003 -- 08/31/2009
2006
Osteoclasts from Transgenic Mice
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5R01AR041336-15), $269,540USD, 09/30/1991 -- 06/30/2010
 
Paget's Disease of Bone/Dysplasia:Advances/Challenges
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skin Diseases (NIAMS) (ID: 3R13AR053436-01S1), $20,000USD, 09/30/2005 -- 02/28/2006
 
Program Project Grant-Pathobiology of Paget's Disease
Roodman, Garson D
National Institutes of Health (NIH), National Institute of Arthritis and Muscoloskeletal and Skn Diseases (NIAMS) (ID: 5P01AR049363-04), $1,234,768USD, 09/29/2003 -- 08/31/2008
2005
Developmental Aspects of Osteoclast Formation In Vitro
Roodman, Garson D
National Institutes of Health (NIH), National Institute on Aging (NIA) (ID: 5R01AG013625-19), $258,550USD, 09/01/1985 -- 03/31/2006